Jeffrey A Meyerhardt

发表

Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

Shuji Ogino, Edward Giovannucci, Marika Hayashi, 2010, The Journal of pathology.

p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis

Shuji Ogino, Aditi Hazra, J. Meyerhardt, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Identification and characterization of neogenin, a DCC-related gene

J. Meyerhardt, A. Look, E. Fearon, 1997, Oncogene.

Tumor TP53 expression status, body mass index and prognosis in colorectal cancer

Reiko Nishihara, Shuji Ogino, Mai Yamauchi, 2012, International journal of cancer.

Systemic therapy for colorectal cancer.

J. Meyerhardt, R. Mayer, Robert J Mayer, 2005, The New England journal of medicine.

A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases

Shuji Ogino, J. Meyerhardt, E. Giovannucci, 2009, Clinical Cancer Research.

Vitamin D Receptor Expression Is Associated with PIK3CA and KRAS Mutations in Colorectal Cancer

Shuji Ogino, J. Meyerhardt, E. Giovannucci, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.

Reiko Nishihara, Shuji Ogino, Mai Yamauchi, 2012, European journal of cancer.

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.

Shuji Ogino, David J Hunter, Aditi Hazra, 2007, Carcinogenesis.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Mingyang Song, Molin Wang, Yin Cao, 2018, European journal of cancer.

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Reiko Nishihara, Shuji Ogino, Mai Yamauchi, 2013, Journal of the National Cancer Institute.

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

Mingyang Song, Yin Cao, Reiko Nishihara, 2015, Gut.

Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

Reiko Nishihara, Shuji Ogino, Mai Yamauchi, 2012, Clinical Cancer Research.

Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer

Shuji Ogino, Jeffrey W. Clark, Massimo Loda, 2005, Clinical Cancer Research.

MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival

Mingyang Song, Yin Cao, Reiko Nishihara, 2016, Clinical Cancer Research.

Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.

Alona Muzikansky, Colleen Lawrence, Jeffrey W. Clark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review

Shuji Ogino, J. Meyerhardt, E. Giovannucci, 2011, International journal of cancer.

Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Shuji Ogino, Edward Giovannucci, Mai Yamauchi, 2011, JAMA.

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

Hajime Uno, Deborah Schrag, John Kidd, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review

Reiko Nishihara, Shuji Ogino, Mai Yamauchi, 2014, Molecular Cancer.

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

John V Heymach, Thomas J Lynch, J. Meyerhardt, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

Alexander Meissner, Reiko Nishihara, Shuji Ogino, 2013, Modern Pathology.

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

Reiko Nishihara, Shuji Ogino, Edward Giovannucci, 2012, The New England journal of medicine.

Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer

Shuji Ogino, Ellen Freed, J. Meyerhardt, 2009, Clinical Cancer Research.

Physical activity and survival after colorectal cancer diagnosis.

Graham A Colditz, Andrew T Chan, G. Colditz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

Shuji Ogino, Massimo Loda, Takako Kawasaki, 2008, Gut.

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.

Ewout W Steyerberg, Hajime Uno, Deborah Schrag, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.